tm logo
ONCOLYTIC IMMUNOTHERAPY
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 17 Mar 2024

Last Applicant/ Owned by

400 Spectrum Center Dr., Suite 2040

Irvine

CA

92618

Serial Number

98452032 filed on 15th Mar 2024

Registration Number

N/A

Correspondent Address

Perry J. Viscounty

Latham & Watkins LLP

650 Town Center Drive, 20th Floor

LATHAM & WATKINS LLP

Costa Mesa,CA 92626

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

ONCOLYTIC IMMUNOTHERAPY

Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders; immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of canRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders; immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders


First Use Date in General

01st Jul 2023

First Use Date in Commerce

01st Jul 2023

Class [005]
Pharmaceutical Products


Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing


First Use Date in General

01st Jul 2023

First Use Date in Commerce

01st Jul 2023

Mark Details


Serial Number

No 98452032

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
17th Mar 2024NEW APPLICATION ENTERED